RGEN - Repligen Corporation

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
36.580
+0.350 (+0.966%)
As of 11:02AM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close36.230
Open36.590
Bid36.780 x 400
Ask36.940 x 400
Day's Range36.285 - 36.960
52 Week Range26.160 - 46.810
Volume100,942
Avg. Volume364,290
Market Cap1.57B
Beta1.11
PE Ratio (TTM)71.59
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • See what the IHS Markit Score report has to say about Repligen Corp.
    Markityesterday

    See what the IHS Markit Score report has to say about Repligen Corp.

    Repligen Corp NASDAQ/NGS:RGEN

  • Investopedia5 days ago

    Top 3 Healthcare Penny Stocks for 2017

    These three healthcare penny stocks are poised for positive performance in the remainder of 2017.

  • Capital Cube9 days ago

    ETFs with exposure to Repligen Corp. : October 9, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Repligen Corp. Here are 5 ETFs with the largest exposure to RGEN-US. Comparing the performance and risk of Repligen Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • See what the IHS Markit Score report has to say about Repligen Corp.
    Markit16 days ago

    See what the IHS Markit Score report has to say about Repligen Corp.

    The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.

  • Capital Cube20 days ago

    ETFs with exposure to Repligen Corp. : September 28, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Repligen Corp. Here are 5 ETFs with the largest exposure to RGEN-US. Comparing the performance and risk of Repligen Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Repligen Corp. :RGEN-US: Earnings Analysis: Q2, 2017 By the Numbers : September 27, 2017
    Capital Cube21 days ago

    Repligen Corp. :RGEN-US: Earnings Analysis: Q2, 2017 By the Numbers : September 27, 2017

    Categories: Yahoo FinanceGet free summary analysis Repligen Corp. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Repligen Corp. – Novavax, Inc., Neurocrine Biosciences, Inc., BioMarin Pharmaceutical Inc., Caladrius Biosciences, Inc., Pfizer Inc., Sangamo Therapeutics, Inc. and Charles River Laboratories International, Inc. (NVAX-US, NBIX-US, BMRN-US, CLBS-US, ... Read more (Read more...)

  • Repligen Corp. breached its 50 day moving average in a Bearish Manner : RGEN-US : September 27, 2017
    Capital Cube21 days ago

    Repligen Corp. breached its 50 day moving average in a Bearish Manner : RGEN-US : September 27, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Repligen Corp.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more (Read more...)

  • See what the IHS Markit Score report has to say about Repligen Corp.
    Markitlast month

    See what the IHS Markit Score report has to say about Repligen Corp.

    The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.

  • Have Investors Already Priced In Repligen Corporation’s (RGEN) Growth?
    Simply Wall St.last month

    Have Investors Already Priced In Repligen Corporation’s (RGEN) Growth?

    Repligen Corporation (NASDAQ:RGEN), a pharmaceuticals, biotechnology and life sciences company based in United States, saw a double-digit share price rise of over 10% in the past couple of months onRead More...

  • Repligen Corp. breached its 50 day moving average in a Bullish Manner : RGEN-US : August 25, 2017
    Capital Cube2 months ago

    Repligen Corp. breached its 50 day moving average in a Bullish Manner : RGEN-US : August 25, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Repligen Corp.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more (Read more...)

  • See what the IHS Markit Score report has to say about Repligen Corp.
    Markit2 months ago

    See what the IHS Markit Score report has to say about Repligen Corp.

    The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.

  • Repligen Corp. – Value Analysis (NASDAQ:RGEN) : August 14, 2017
    Capital Cube2 months ago

    Repligen Corp. – Value Analysis (NASDAQ:RGEN) : August 14, 2017

    Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Repligen Corp. a score of 88. Our analysis is based on comparing Repligen Corp. with the following peers – Novavax, Inc., Neurocrine Biosciences, Inc., BioMarin Pharmaceutical Inc., General Electric Company, Thermo Fisher Scientific Inc., Caladrius Biosciences, Inc., Pfizer Inc., Sangamo Therapeutics, Inc., Charles River Laboratories International, Inc. ... Read more (Read more...)

  • Repligen Corp. breached its 50 day moving average in a Bullish Manner : RGEN-US : August 14, 2017
    Capital Cube2 months ago

    Repligen Corp. breached its 50 day moving average in a Bullish Manner : RGEN-US : August 14, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Repligen Corp.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more (Read more...)

  • See what the IHS Markit Score report has to say about Repligen Corp.
    Markit2 months ago

    See what the IHS Markit Score report has to say about Repligen Corp.

    The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Over the last one-month, outflows of investor capital in ETFs holding RGEN totaled $690 million.

  • Thomson Reuters StreetEvents2 months ago

    Edited Transcript of RGEN earnings conference call or presentation 3-Aug-17 12:30pm GMT

    Q2 2017 Repligen Corp Earnings Call

  • Associated Press2 months ago

    Repligen beats Street 2Q forecasts

    The Waltham, Massachusetts-based company said it had net income of 24 cents per share. Earnings, adjusted for one-time gains and costs, were 20 cents per share. The results surpassed Wall Street expectations. ...

  • Repligen Corp. breached its 50 day moving average in a Bearish Manner : RGEN-US : July 31, 2017
    Capital Cube3 months ago

    Repligen Corp. breached its 50 day moving average in a Bearish Manner : RGEN-US : July 31, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Repligen Corp.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more (Read more...)

  • Top Ranked Momentum Stocks to Buy for July 3rd
    Zacks4 months ago

    Top Ranked Momentum Stocks to Buy for July 3rd

    Top Ranked Momentum Stocks to Buy for July 3rd

  • Investopedia4 months ago

    Top 3 Healthcare Penny Stocks for 2017

    These three penny health care stocks are poised for a positive 2017.

  • Capital Cube4 months ago

    ETFs with exposure to Repligen Corp. : June 19, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Repligen Corp. Here are 5 ETFs with the largest exposure to RGEN-US. Comparing the performance and risk of Repligen Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Repligen Corp. :RGEN-US: Earnings Analysis: Q1, 2017 By the Numbers : June 16, 2017
    Capital Cube4 months ago

    Repligen Corp. :RGEN-US: Earnings Analysis: Q1, 2017 By the Numbers : June 16, 2017

    Categories: Yahoo FinanceGet free summary analysis Repligen Corp. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Repligen Corp. – Novavax, Inc., Neurocrine Biosciences, Inc., BioMarin Pharmaceutical Inc., General Electric Company, Thermo Fisher Scientific Inc., Caladrius Biosciences, Inc., Pfizer Inc., Sangamo Therapeutics, Inc., Charles River Laboratories ... Read more (Read more...)

  • Investopedia5 months ago

    Top 3 Healthcare Penny Stocks for 2017

    These three penny health care stocks are poised for a positive 2017.

  • Thomson Reuters StreetEvents5 months ago

    Edited Transcript of RGEN earnings conference call or presentation 4-May-17 12:30pm GMT

    Q1 2017 Repligen Corp Earnings Call

  • Associated Press5 months ago

    Repligen tops Street 1Q forecasts

    On a per-share basis, the Waltham, Massachusetts-based company said it had net income of 9 cents. Earnings, adjusted for one-time gains and costs, were 15 cents per share. The results beat Wall Street ...